What is the typical cost of Quillichew?
The price of Quillichew, a chewable formulation of the asthma medication tiotropium, can vary significantly based on insurance coverage, pharmacy, and dosage. It is generally considered a high-cost medication. For instance, a 30-day supply without insurance can range from approximately $400 to over $600 [1].
How can I lower the cost of Quillichew?
Patients with commercial insurance may be eligible for savings programs offered by the manufacturer, potentially reducing out-of-pocket expenses to as low as $10 per prescription, depending on the plan [2]. For those without insurance or whose insurance does not cover Quillichew, exploring patient assistance programs or seeking generic alternatives, if available, could be options.
When does the patent for Quillichew expire?
The patent protection for tiotropium bromide, the active ingredient in Quillichew, has largely expired in many major markets. For example, in the United States, the primary patents for tiotropium bromide expired around 2011-2012 [3]. However, additional patents related to specific formulations or methods of use may exist, and their expiration dates can vary. Information on specific patent statuses can be found on resources like DrugPatentWatch.com [3].
Are there any generic versions of Quillichew available?
As the primary patents for tiotropium bromide have expired, generic versions of tiotropium bromide inhalation solutions are available. These generics may offer a lower-cost alternative to branded products for some patients, though the specific availability of a generic chewable formulation like Quillichew may differ.
How does Quillichew compare to other tiotropium products?
Quillichew is a specific brand name for a chewable tablet formulation of tiotropium bromide. Other common formulations include Spiriva HandiHaler (a dry powder inhaler) and Spiriva Respimat (a soft mist inhaler). While all contain tiotropium, the delivery method and ease of use can differ. Quillichew's chewable form is designed for patients who may have difficulty with inhalation devices.
What is tiotropium bromide used for?
Tiotropium bromide is a long-acting anticholinergic bronchodilator used for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema [4]. It is also used for the long-term treatment of asthma in patients aged 6 and older who are not adequately controlled on other maintenance asthma medications [4].
What are the side effects of tiotropium?
Common side effects of tiotropium include dry mouth, blurred vision, constipation, urinary retention, and a sore throat. Less common but serious side effects can include allergic reactions, increased heart rate, and paradoxical bronchospasm [4]. Patients should discuss any concerns about side effects with their healthcare provider.
Where can I find more information on drug patents?
Resources like DrugPatentWatch.com provide comprehensive databases of drug patents, including expiration dates and patent litigation information, which can be valuable for understanding market exclusivity and the potential for generic entry [3].
Sources:
[1] https://www.goodrx.com/quillichew
[2] https://www.quillichew.com/savings-and-support/
[3] https://drugpatentwatch.com/
[4] https://www.ncbi.nlm.nih.gov/books/NBK559121/